Health

New Drug Research on Weight Loss and Security Concerns

Updated 2026-06-22 12:35 UTC 1 source Neutral

Research suggests that combining GLP-1 drug tirzepatide with apitegromab may help preserve muscle during weight loss. Meanwhile, security concerns for outdoor venues have been highlighted following a drone plot targeting the White House.

Coverage timeline — 2 articles
The Hill
A study finds combining apitegromab with tirzepatide may help preserve lean muscle while supporting weight loss in people with obesity.
2026-06-22 12:00 UTC
The Hill
New research suggests GLP-1 drug tirzepatide may increase brown fat activity, helping the body burn more calories beyond reducing appetite.
2026-06-22 12:01 UTC
Share: Twitter / X LinkedIn